Cortex Pharmaceuticals Inc/De
Glen Rock, US
Biotech
Founders & leadership
KE
Kathryn E. MacFarlaneMember of the Board of Directors
JE
Jeff E. MargolisExecutive Officer, Director
JS
James S.J. ManusoExecutive Officer, Director
AS
Arnold S. LippaExecutive Officer, Director
JE
James E. SapirsteinMember of the Board of Directors
RE
Richard E. PurcellSenior Vice President of Research and Development
RN
Robert N. WeingartenChief Financial Officer and Member of the Board of Directors
Reported raises · per SEC filings
Form D private placements$193.3KraisedAug 2020 · 2 investors · Biotechnology
Rule 506(b)$2MofferedAug 2020 · 1 investors · Biotechnology
Rule 506(b)$250.8KraisedSep 2018 · 10 investors · Biotechnology
Rule 506(b)$75KraisedSep 2017 · 1 investors · Biotechnology
Rule 506(b)$50KraisedMar 2017 · 1 investors · Biotechnology
Rule 506(b)$185KraisedJan 2017 · 4 investors · Biotechnology
Rule 506(b)$100KraisedJan 2016 · 1 investors · Biotechnology
Rule 506(b)$721.2KraisedSep 2015 · 8 investors · Biotechnology
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.